Application of next-generation metagenomic sequencing in the diagnosis and treatment of acute spinal infections
Microbiological culture
Medical record
DOI:
10.1016/j.heliyon.2023.e13951
Publication Date:
2023-02-22T04:39:52Z
AUTHORS (6)
ABSTRACT
The purpose of this study was to verify the value metagenomic next-generation sequencing (mNGS) in detecting pathogens causing acute spinal infection by reviewing results mNGS 114 patients.A total patients were included from our hospital. Samples (tissue/blood) sent for detection, and remaining samples microbiology laboratory pathogen culture, smear, histopathological analysis, other tests. Patients' medical records reviewed determine their rates time needed, guidance antibiotic treatment clinical outcomes.mNGS showed a satisfying diagnostic positive percent agreement 84.91% (95% confidence interval (CI): 6.34%-96.7%), compared 30.19% CI: 21.85%-39.99%) culture 43.40% 31.39%-49.97%) conventional methods (p < 0.0125), found 46 smear negative samples. required identification using ranged 29 h 53 h, which an advantage over (90.88 ± 8.33 h; P 0.05). also played important role optimizing regimens with obtained methods. success rate (TSR) mNGS-guided (20/24, 83.33%) significantly higher than that empirical antibiotics (13/23, 56.52%) (P 0.0001).mNGS shows promising potential pathogenic diagnosis infections may enable clinicians make more timely effective adjustments regimens.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....